XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Pain In Capital
Accumulated Deficit
Balance at Dec. 31, 2021 $ 303,129 $ 4 $ 471,449 $ (168,324)
Balance, shares at Dec. 31, 2021   39,736,914    
Issuance of common stock upon exercise of stock options 93   93  
Issuance of common stock upon exercise of stock options, shares   10,099    
Issuance of common stock upon vesting of restricted stock, shares   224,000    
Shares withheld for taxes (1,106)   (1,106)  
Shares withheld for taxes, shares   (85,197)    
Stock-based compensation expense 4,350   4,350  
Net income 4,618     4,618
Balance at Mar. 31, 2022 311,084 $ 4 474,786 (163,706)
Balance, shares at Mar. 31, 2022   39,885,816    
Balance at Dec. 31, 2021 303,129 $ 4 471,449 (168,324)
Balance, shares at Dec. 31, 2021   39,736,914    
Net income (17,920)      
Balance at Jun. 30, 2022 293,267 $ 4 479,507 (186,244)
Balance, shares at Jun. 30, 2022   40,020,755    
Balance at Mar. 31, 2022 311,084 $ 4 474,786 (163,706)
Balance, shares at Mar. 31, 2022   39,885,816    
Issuance of common stock upon exercise of stock options 183   183  
Issuance of common stock upon exercise of stock options, shares   17,854    
Issuance of common stock upon vesting of restricted stock, shares   100,731    
Shares withheld for taxes (203)   (203)  
Shares withheld for taxes, shares   16,354    
Stock-based compensation expense 4,335   4,335  
Net income (22,538)     (22,538)
Balance at Jun. 30, 2022 293,267 $ 4 479,507 (186,244)
Balance, shares at Jun. 30, 2022   40,020,755    
Balance at Dec. 31, 2022 292,338 $ 4 530,448 (238,114)
Balance, shares at Dec. 31, 2022   42,954,820    
Issuance of common stock upon exercise of stock options 3   3  
Issuance of common stock upon exercise of stock options, shares   713    
Issuance of common stock upon vesting of restricted stock, shares   3,205    
Shares withheld for taxes (10)   (10)  
Shares withheld for taxes, shares   (1,307)    
Stock-based compensation expense 4,765   4,765  
Net income (30,881)     (30,881)
Balance at Mar. 31, 2023 266,215 $ 4 535,206 (268,995)
Balance, shares at Mar. 31, 2023   42,957,431    
Balance at Dec. 31, 2022 $ 292,338 $ 4 530,448 (238,114)
Balance, shares at Dec. 31, 2022   42,954,820    
Issuance of common stock upon exercise of stock options, shares 946      
Net income $ (63,284)      
Balance at Jun. 30, 2023 239,061 $ 4 540,455 (301,398)
Balance, shares at Jun. 30, 2023   43,066,158    
Balance at Mar. 31, 2023 266,215 $ 4 535,206 (268,995)
Balance, shares at Mar. 31, 2023   42,957,431    
Issuance of common stock upon exercise of stock options 1   1  
Issuance of common stock upon exercise of stock options, shares   233    
Purchase of common stock under ESPP 225   225  
Purchase of common stock under ESPP Shares   108,494    
Stock-based compensation expense 5,023   5,023  
Net income (32,403)     (32,403)
Balance at Jun. 30, 2023 $ 239,061 $ 4 $ 540,455 $ (301,398)
Balance, shares at Jun. 30, 2023   43,066,158